Quick Takeaways
- Silver Point Capital L.P. filed SCHEDULE 13D/A for Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ).
- Disclosed ownership: 12%.
- Date of event: 08 Dec 2025.
Silver Point Capital L.P. - 08 Dec 2025 SCHEDULE 13D/A Report for Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ)
- Filing Manager
- Silver Point Capital L.P.
- Reporting Manager
- Silver Point Capital, L.P.
- Symbol
- MNKTQ
- Shares outstanding
- 39,518,605 shares
- Disclosed Ownership
- 4,702,714 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13D/A
- Filing time
- 10 Dec 2025, 18:29:34 UTC
- Date of event
- 08 Dec 2025
- Previous filing
- 05 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Silver Point Capital L.P. disclosed 12% ownership in Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ) on 08 Dec 2025."
What Changed
- Previous schedule filing date: 05 Nov 2025.
- Current filing was accepted on 10 Dec 2025, 18:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Silver Point Capital, L.P. | 12% | 4,702,714 | 0 | 4,702,714 | /s/ Steven Weiser | Steven Weiser/Authorized Signatory | 0001332784 |
| Edward A. Mule | 12% | 4,702,714 | 0 | 4,702,714 | /s/ Steven Weiser | Steven Weiser/Attorney-in-fact | 0001029625 |
| Robert J. O'Shea | 12% | 4,702,714 | 0 | 4,702,714 | /s/ Steven Weiser | Steven Weiser/Attorney-in-fact | 0001382617 |